Imaging method for obtaining three-dimensional structure of experimental animal embryo heart at high throughput
By optimizing the sample fixation and transparency method, combined with the ZEISS Lightsheet Z1 light sheet microscope platform, the problem of high throughput and high resolution in the existing technology is solved, and the clear three-dimensional structural image of mouse embryonic heart is quickly obtained, and the image quality is solved. Poor and sample installation challenges are problematic and suitable for a wide range of applications.
Patent Information
- Application Number
- CN202410538215.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-30
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-04-30
AI Technical Summary
Existing experimental animal embryonic cardiac imaging technology is difficult to achieve high throughput and high resolution, especially in the recognition of mouse embryonic cardiac morphology. The image quality is poor and there are challenges in sample installation, which cannot effectively solve the problem of determining embryonic cardiac structure abnormality. .
A high-throughput imaging method for obtaining the three-dimensional structure of the embryo heart of experimental animals, including fixation, dehydration or degreasing of the fixation solution, fluorescence imaging in a transparent tube, using the ZEISS Lightsheet Z1 light sheet microscope platform, combining formaldehyde and glutaraldehyde Techniques such as fixing liquid, BABB organic transparent agent and EZ view water-soluble transparent agent optimize sample fixation and transparency methods to achieve efficient three-dimensional structural imaging.
It is realized that the clear three-dimensional structural diagram of the embryonic heart without fluorescence is obtained in the shortest 5 hours, and the clear image of the heart with fluorescence is obtained in the 3 hours, which improves imaging efficiency and resolution, ensures image quality, and simplifies the Operation process, suitable for a wide range of applications.
Smart Images

Figure CN118937023A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of experimental animal imaging, and in particular relates to an imaging method for acquiring the three-dimensional structure of an experimental animal embryonic heart with high throughput. Background Art
[0002] Congenital heart disease (CHD) is one of the most common congenital diseases, affecting approximately 0.8% to 1.2% of fetuses. Due to the high similarity between mouse and human heart development, scientists often use mice as a model to study the mechanism of CHD. In terms of mechanism research, identifying phenotypic defects during heart development is a critical first step.
[0003] Existing methods for identifying embryonic cardiac phenotypes include:
[0004] (1) Scanning laser fluorescence microscopy techniques such as confocal microscopy, light sheet imaging, and two-photon imaging ([1] Esteban, I., Schmidt, P., Desgrange, A., Raiola, M., S.,Meilhac,SM,Kobbelt,L.,and Torres,M.(2022).Pseudodynamic analysis of heart tube formation in themmouse reveals strong regional variability and early left–right asymmetry.NatCardiovasc Res 1,504–517.10.1038 / s44161-022-00065-1. [2] Dominguez, MH, Krup, AL, Muncie, JM, and Bruneau, BG (2023). Graded mesoderm assembly governs cellfate and morphogenesis of the early mammalian heart. Cell 186,479-496.e23.10.1016 / j.cell.2023.01.001.[3]Ivanovitch,K.Live imaging of heart tubedevelopment in mouse reveals alternating phases of cardiac differentiation and morphogenesis.);
[0005] (2) Stereological techniques such as serial tissue sections or high-resolution microscopy (HREM) ([1] De Boer, BA, Van Den Berg, G., De Boer, PAJ, Moorman, AFM, and Ruijter, JM (2012). Growth of the developing mouse heart: An interactive qualitative and quantitative 3D atlas. Developmental Biology 368, 203–213.10.1016 / j.ydbio.2012.05.001. [2] Le Garrec, J.-F., JN,Desgrange,A.,Ivanovitch,KD, E.,Bangham,JA,Torres,M.,Coen,E.,Mohun,TJ,andMeilhac,SM(2017).A predictive model of asymmetric morphogenesis from 3Dreconstructions of mouse heart looping dynamics.eLife 6,e28951.10.7554 / eLife.28951.);
[0006] (3) Tomographic strategies, including micro-computed tomography (micro-CT), optical coherence tomography (OCT), and optical projection tomography (OPT) ([1] Li-Villarreal, N., Rasmussen, TL, Christiansen, AE, Dickinson, ME, and Hsu, C.-W. (2023). Three-dimensional microCT imaging of mouse heart development from early post-implantation to late fetal stages. MammGenome 34, 156–165.10.1007 / s00335-022-09976-7. [2] Wang, S., Lopez, AL, Larin, KV, Overbeek, PA, and Larina, IV (2015). Live four-dimensional optical coherence tomography reveals embryonic cardiac phenotype in mousemutant.J.Biomed.Opt.20,1.10.1117 / 1.JBO.20.9.090501.[3]Dalmasso,G.,Musy,M.,Niksic,M.,Robert-Moreno,A., -Careaga, C., Sanz-Ezquerro, JJ, and Sharpe, J. (2022). 4D reconstruction of murine developmental trajectories using sphericalharmonics. Developmental Cell 57, 2140-2150.e5.10.1016 / j.devcel.2022.08.005.).
[0007] However, they inevitably have their own limitations and cannot achieve high throughput. For example, laser fluorescence microscopy is only applicable to hearts with fluorescence, confocal microscopy and two-photon imaging take a long time, light sheet imaging takes a short time but sample processing and loading takes a long time, tissue sections cannot achieve three-dimensional reconstruction well, HREM has sufficient resolution, but it also has the limitation of long sample processing and slicing time and cannot achieve high throughput, and tomographic imaging strategies generally have insufficient resolution, which brings more difficulties to the determination of abnormal embryonic heart structure.
[0008] Since the light sheet microscope was applied to the field of life sciences in 2004, it has shown extremely high efficiency in three-dimensional imaging of developmental processes (Huisken, J., Swoger, J., Del Bene, F., Wittbrodt, J., and Stelzer, EHK (2004). Optical Sectioning Deep Inside Live Embryos by Selective Plane Illumination Microscopy. Science 305, 1007–1009.10.1126 / science.1100035). In recent years, many technical innovations based on the light sheet platform have been developed, such as sample mounting methods (Laroche, T., Burri, O., Dubey, LK, and Seitz, A. (2019). Development of Sample-Adaptable Holders for Lightsheet Microscopy. Front. Neuroanat. 13, 26.10.3389 / fnana.2019.00026.), tissue transparent technology ([1]
[0009] H., V., A., M.,andSedmera,D.(2021).Tissue clearing and imaging methods for cardiovasculardevelopment.iScience 24,102387.10.1016 / j.isci.2021.102387.[2]Ueda,HR,Ertürk,A.,Chung,K.,Gradinaru,V., A., Tomancak, P., and Keller, PJ (2020). Tissue clearing and its applications in neuroscience. Nat Rev Neurosci 21, 61–79. 10.1038 / s41583-019-0250-1.), image processing (Gibbs, HC, Mota, SM, Hart, NA, Min, SW, Verno, AO, Pritchard, AL, Sen, A., Vitha, S., Sarasamma, S., McIntosh, AL, et al. (2021). Navigating the Light-Sheet Image Analysis Software Landscape: Concepts for Driving Cohesion From Data Acquisition to Analysis. Front. Cell Dev. Biol. 9, 739079. 10.3389 / fcell.2021.739079.), etc., have developed rapidly. These optimizations have promoted the widespread application of light sheet microscopy in the field of neuroscience. However, due to the small size of the embryonic heart, the difficulty in clarity, and the inability to achieve high throughput, light sheet microscopy has not received much attention in the identification of mouse embryonic heart morphology.Although it has been reported to be used to image the embryonic heart, the image quality is poor and there are challenges with sample mounting ([1]Sereti, K.-I., Nguyen, N.B., Kamran, P., Zhao, P., Ranjbarvaziri, S., Park, S., Sabri, S., Engel, J.L., Sung, K., Kulkarni, R.P., et al. (2018). Analysis of cardiomyocyte clonal expansion during mouse heart development and injury. Nat Commun 9, 754.10.1038 / s41467-018-02891-z. [2]Fei, P., Lee, J., Packard, R.S., Sereti, K.-I., Xu, H., Ma, J., Ding, Y., Kang, H., Chen, H., Sung, K., et al. (2016). Cardiac Light-Sheet Fluorescent Microscopy for Multi-Scale and Rapid Imaging of Architecture and Function. SciRep 6, 22489.10.1038 / srep22489.). Mounting methods such as clamping may affect sample stability, and the use of glue mounting may obscure certain structures. In addition, the use of agarose embedding will greatly extend the time required for tissue clearing and refractive index matching. Summary of the invention
[0010] In view of the above-mentioned deficiencies in the prior art, the present invention provides a high-throughput imaging method for acquiring the three-dimensional structure of the embryonic heart of an experimental animal.
[0011] A high-throughput imaging method for acquiring the three-dimensional structure of an embryonic heart of an experimental animal, the imaging method comprising the following steps:
[0012] (1) Collect the embryonic hearts of experimental animals and fix them using fixative;
[0013] (2) Dehydrating or defatting the embryonic heart fixed in step (1) and then performing a transparent treatment;
[0014] (3) The embryonic heart after the clearing treatment was placed in a transparent tube, and then placed in an imaging chamber filled with a transparent solution with a refractive index of 1.41 to 1.47, and fluorescence imaging was performed.
[0015] Preferably, the refractive index of the transparent solution poured into the imaging chamber is 1.45, which has the best imaging effect.
[0016] Preferably, if the embryonic heart does not express exogenous fluorescent protein, imaging is performed using a method that enhances tissue autofluorescence;
[0017] If the embryonic heart expresses exogenous fluorescent protein, the excitation light corresponding to the exogenous fluorescent protein is used for fluorescence imaging.
[0018] More preferably, if the embryonic heart does not express exogenous fluorescent proteins, imaging is performed using a method that enhances tissue autofluorescence, in which case:
[0019] In step (1), the embryonic heart of the experimental animal is from an embryo of E10.5 to E14.5, and when fixation is performed using a fixative, formaldehyde solution is first used for fixation and then glutaraldehyde solution is used for fixation;
[0020] In step (1), the embryonic heart of the experimental animal is from an embryo of E15.5 to E18.5, and is fixed with a glutaraldehyde solution;
[0021] If the embryonic heart expresses exogenous fluorescent protein, the excitation light corresponding to the exogenous fluorescent protein is used for fluorescence imaging. In this case, in step (1), formaldehyde solution is used for fixation.
[0022] For embryonic hearts that do not express exogenous fluorescent proteins, that is, do not have fluorescence, myocardial tissue exhibits autofluorescence due to the presence of tetrapyrroheme and myosin in myoglobin. This natural high fluorescence is generally considered a disadvantage because it may compete with the fluorescence of immunohistochemistry. However, this application makes use of this natural fluorescence. Glutaraldehyde exists in its oligomeric form and reacts with protein molecules to form crosslinks, leaving many free aldehyde groups to react with amino groups in the tissue, resulting in strong fluorescence inside the tissue. We have utilized the natural autofluorescence of myocardial tissue and enhanced the fluorescence with glutaraldehyde, improving the visualization of tissue morphology by laser light sheet imaging, thereby making the internal structure clear and promoting the widespread adoption of this technology.
[0023] For embryonic hearts that do not express exogenous fluorescent proteins, for embryos from E10.5 to E14.5, fixation with formaldehyde first can better fix the cell morphology; and for embryos from E15.5 to E18.5, since it is no longer necessary to pay attention to the morphology of the cells in the later stages of the embryo, but only the gross structure, formaldehyde fixation is not required at this time, saving the time required for fixation.
[0024] The fixation steps for large embryos are different. The main purpose is to save time and effort to achieve high throughput. If you are not in a hurry to get results, large embryos can also be fixed in formaldehyde overnight, but the final results will not be much different, because the cell density of large embryos is too high to distinguish single cell morphology, so it is not necessary. Small embryos can also be fixed directly with glutaraldehyde instead of formaldehyde, but the cell morphology will not look clear enough and only the general structure can be seen.
[0025] For embryonic hearts that have been introduced with fluorescent proteins, since the fluorescence emitted by the fluorescent proteins is strong enough, no additional treatment is required to enhance the fluorescence and the next step can be carried out directly after fixation.
[0026] When using formaldehyde solution for fixation, it is generally sufficient to fix for 2 to 3 hours at room temperature. Extending the fixation time is also possible, but the fixation effect will not change much. If you want to keep it overnight (generally more than 12 hours), you can place it at 4°C for fixation, and the fixation time should not be less than 12 hours.
[0027] When using glutaraldehyde solution for fixation, the fixation time should not be less than 2 hours.
[0028] More preferably, if the embryonic heart does not express exogenous fluorescent protein, imaging is performed using a method of enhancing tissue autofluorescence. In this case: in step (2), the heart is first rinsed with a buffer solution, then dehydrated, and then defatted and transparentized; dehydration is performed using an alcohol solution with a concentration gradually increasing until pure alcohol, and degreasing and transparentizing are performed using a benzyl alcohol: benzyl benzoate solution (BABB organic transparent agent);
[0029] If the embryonic heart expresses exogenous fluorescent protein, the excitation light corresponding to the exogenous fluorescent protein is used for fluorescence imaging. At this time: in step (2), gradient defatting is performed using tetrahydrofuran solutions with increasing concentrations; and transparent treatment is performed using iohexol-urea solution (EZ view water-soluble transparent agent).
[0030] Further preferably, when the dehydration is performed using an alcohol solution with a concentration increasing in sequence until pure alcohol is used for gradient dehydration, the volume concentration gradient of the alcohol is set to 50%, 75%, 90%, 100% and 100% in sequence; and the processing time for each volume concentration gradient is 30 minutes;
[0031] The volume ratio of benzyl alcohol to benzyl benzoate in the benzyl alcohol: benzyl benzoate solution is 1:2;
[0032] When degreasing using tetrahydrofuran solutions with increasing concentrations for gradient degreasing, for embryonic hearts less than E12.5 days, the volume concentration gradient of the tetrahydrofuran solution is set to 10%, 20%, and 30% in sequence; for embryonic hearts more than E12.5 days, the volume concentration gradient is increased to 40%; the treatment time for each volume concentration gradient is 30 minutes;
[0033] The composition of the iohexol-urea solution is 5 g of iohexol and 2.625 g of urea dissolved in 2 ml of 0.03 M PBS (the final refractive index is about 1.51).
[0034] The embryonic heart without fluorescence undergoes dehydration and clearing, while the one with fluorescence undergoes defatting and clearing. BABB organic clearing agent is used for clearing the embryonic heart without fluorescence, which is easy to prepare and has good morphological imaging effect after clearing. Of course, EZ view water-soluble clearing agent can also be used for clearing the embryonic heart without fluorescence, but first of all, EZ view is not easy to prepare, and it takes at least 4-5 hours to dissolve and prepare. Secondly, the morphological imaging effect after clearing is not as good as that of BABB organic clearing agent. However, the fluorescent heart uses EZ view water-soluble clearing agent, and BABB organic clearing agent cannot be used because BABB organic clearing agent will quench the fluorescence.
[0035] Preferably, in order to save operation steps, the transparent tube is placed in a transparent tube during the transparent treatment, and the fluorescent imaging is directly performed after the transparent treatment. The transparent tube is preferably a glass tube.
[0036] Preferably, during fluorescence imaging, the fluorescence imaging is performed using a ZEISS Lightsheet Z1 light sheet microscope platform, using an X5 / 0.16 air detection lens and an X5 / 0.1 illumination lens. The imaging chamber is perfused with a glycerol aqueous solution having a volume concentration of 87%. The refractive index of the 87% glycerol aqueous solution is about 1.45.
[0037] More preferably, during fluorescence imaging, a first magnet is fixed to the bottom end of a sample fixing rod provided on the ZEISS Lightsheet Z1 light sheet microscope platform, and a sampling rod is used to fix the transparent tube on the sample fixing rod.
[0038] The sampling rod has a certain elasticity, and the top surface is provided with a second magnet for oppositely attracting and fixing with the first magnet, and the bottom is provided with an insertion section for plugging and matching with the inner cavity of the transparent tube, and the diameter gradually decreases from top to bottom.
[0039] The refractive index of the X5 / 0.16 air detection lens is not adjustable and is fixed at 1.45 with an accuracy of 0.001, but it is not that sensitive to changes in the refractive index. In theory, for the ZEISS Lightsheet Z1 light sheet microscope X5 / 0.16 air detection lens (n=1.45), the best imaging results can be obtained when both the medium and the sample have the same refractive index (RI) of 1.45 as the detection lens. However, our experiments showed that the 5x lens can tolerate a wider range of RI changes compared to the 20x lens. Although the imaging chamber was filled with 87% glycerol (RI approximately 1.45), light also passed through the glass tube (RI approximately 1.51) and BABB (RI approximately 1.56), but this did not significantly affect the quality of embryo imaging.
[0040] Preferably, the experimental animal is a mouse or a rat.
[0041] Beneficial effects of the present invention:
[0042] (1) By modifying the sample loading equipment and optimizing the sample fixation and clearing methods, we were able to obtain a clear three-dimensional structure image of the embryonic heart without fluorescence in as short as 5 hours after ex vivo separation, and a clear three-dimensional structure image of the heart with fluorescence in about 3 hours after fixation. The modified consumables are all convenient and easy to obtain, and all the reagents used are commercially available. The technology is stable, highly reproducible, and easy to operate, making it easy to be widely promoted. (2) Using the ZEISS Lightsheet Z1 light sheet microscope platform, we were able to obtain about 30 images of the three-dimensional structure of the transparent mouse embryonic heart per hour. For the embryonic hearts of E10.5-E12.5, the X and Y axis resolutions were less than 1μm, and the Z axis resolution was 1-2μm. For the embryonic hearts of E18.5, the X and Y axis resolutions were about 2μm, and the Z axis resolution was 5-7μm. This has achieved a high-throughput imaging method for obtaining clear three-dimensional structures of the mouse embryonic heart.
[0043] (3) Neither the fixation method nor the clearing method caused significant deformation of the embryonic heart. The heart fixed with BABB organic clearing agent could be stored for a long time, which was convenient for repeated photography or preservation until the photography time. The embryonic heart cleared with EZ view water-soluble clearing agent could be stored for three days, which was conducive to experimental operation.
[0044] In summary, the method of the present invention solves the problems of high throughput, poor resolution and complex loading that cannot be achieved by existing light sheet imaging methods. The method of the present invention can: quickly obtain the three-dimensional structure of the isolated embryonic heart; achieve high throughput without compromising image quality; ensure that the materials used are easily accessible, cost-effective and suitable for a wide range of applications. BRIEF DESCRIPTION OF THE DRAWINGS
[0045] Figure 1 It is a schematic diagram of the structure of the fixed rod.
[0046] Figure 2 Schematic diagram of the structure of the sampling rod and glass tube.
[0047] Figure 3 Schematic diagram of the assembly structure of the glass tube, sampling rod and fixing rod.
[0048] Figure 4 This is a physical picture of the light sheet microscope loading device used for high-throughput imaging of embryonic heart specimens in this application, wherein: A: commercially available hollow ear spoon; B: glass tube placed on the gun tip box; C: sample fixing rod; D: sampling rod; E: glass tube; F: combined loading structure; G: operational settings for imaging using ZEISS Lightsheet Z.1.
[0049] Figure 5 The following are representative images of the embryonic heart at different stages taken in Example 1, wherein, by row: A1-F1 is a three-dimensional representative image, A2-F2 is a representative slice image of the ventral side of the heart, A3-F3 is a representative slice image of the dorsal side of the heart, and A4-F5 is a three-dimensional cross-sectional image of the heart; by column: A1-A5 is E10.5 days, B1-B5 is E11.5 days, C1-C5 is E12.5 days, D1-D5 is E13.5 days, E1-E5 is E14.5 days, and F1-F5 is E18.5 days. Scale bar: 100 μm.
[0050] Figure 6 E11.5 Wnt1-Cre; Rosa26 in Example 2 mTmG Figure 1. Gross and slice images of mouse embryonic heart, where AB: 10% THF-20% THF-30% THF degreasing, half an hour each; CD: 10% THF-20% THF-30% THF-40% THF-50% THF degreasing, half an hour each; EF: 10% THF-20% THF-30% THF degreasing, 3 hours each. Scale bar: 200μm.
[0051] Figure 7 Mef2C-Cre; Rosa26 photographed in Example 2 mTmG Representative images of mouse embryos, including: AC: gross image and sagittal slices of E11.5 mice; DF: gross image and slices of E15.5 mice; GI: gross image and coronal slices of E18.5 mice. Scale bar: 200 μm. DETAILED DESCRIPTION
[0052] In this application, the ZEISS Lightsheet Z1 light sheet microscope platform was used for fluorescence imaging.
[0053] like Figures 1 to 3As shown, the ZEISS Lightsheet Z1 light sheet microscope platform comes with a sample fixing rod 1, which is a metal rod. Generally, the bottom end of the fixing rod 1 is used to connect the adapter and then adhere the sample to be tested. In this application, the fixing rod 1 is modified, and a magnet 2 is glued to the bottom end with strong glue. In addition, a sampling rod 4 is designed. The top surface of the sampling rod 4 is also provided with a magnet 3. The magnet 3 is glued to the top surface of the sampling rod 4 with strong glue. When in use, the sampling rod 4 is sucked on the magnet 3 on the bottom surface of the fixing rod 2 through the magnet 3 on the top surface, so that it is convenient to take and place the sampling rod 4. The bottom of the sampling rod 4 has a plug-in section with a diameter that gradually decreases from top to bottom. The plug-in section is used to extend into the glass tube 5 where the heart is placed, and plug-in with the inner wall of the glass tube 5, so that the glass tube 5 and the sampling rod 4 are fixed and placed under the fixing rod 1 for imaging. The material of the sampling rod 4 can be wood, which has a certain elasticity, which is conducive to the plug-in cooperation between the sampling rod 4 and the glass tube 5.
[0054] like Figure 4 The figure shows a real-life image of a light sheet microscope loading device for high-throughput imaging of embryonic heart specimens in this application. Figure 4 (A) is a commercially available hollow ear spoon, about 3.8 mm in width and 158 mm in length, used to transfer dehydrated embryonic heart specimens into a glass tube containing clearing solution. Figure 4 (B) shows a glass tube placed on a pipette tip box. The glass tube is a modified Pasteur tube that can be placed in batches on a 200 μL pipette tip box commonly used in the laboratory for placing embryonic heart samples in batches. Figure 4 (C) is a sample fixing rod. The first magnet is fixed to the bottom surface of the sample fixing rod provided on the ZEISS Lightsheet Z1 light sheet microscope platform by superglue. Figure 4 (D) is a homemade sampling rod, including a wooden sampling rod at the bottom, and a second magnet is fixed to the top surface of the wooden sampling rod by superglue. Figure 4 (E) is a glass tube, which is a modified Pasteur tube with a uniformly sealed bottom and cut into 3 cm lengths. The glass tube contains an embryonic heart immersed in a clearing solution. Figure 4 (F) The combined loading structure integrates the fixing rod, sampling rod and glass tube, ready for the imaging process. Figure 4 (G) Operational setup for imaging using ZEISS Lightsheet Z.1, using a 5x / 0.16 (n=1.45) detection optical system, with the imaging chamber filled with 87% glycerol aqueous solution (refractive index of approximately 1.45); tweezers are used to easily manipulate and replace samples at the position indicated by the yellow arrow. This design significantly simplifies the sample replacement process and improves the efficiency of high-throughput imaging workflows.
[0055] Example 1
[0056] 1. For imaging of embryonic hearts without fluorescence, the embryonic hearts were from mouse embryos at E10.5-E14.5. The specific steps are as follows:
[0057] (1) To enhance the visualization of cell morphology, samples were first fixed with 4% formaldehyde (PFA, mass-volume ratio, 4 g formaldehyde dissolved in 100 ml PBS, pH 7.4, final concentration of PBS was 0.01 M, the same below) at 4°C overnight and then fixed with 2.5% glutaraldehyde (volume ratio, solvent was PBS with a pH of 7.4, the same below) at room temperature for 2 h.
[0058] (2) The embryonic heart was rinsed twice with PBS (pH = 7.4), and then dehydrated through a concentration gradient (volume concentration, ethanol-water solution) alcohol series (50%, 75%, 90% and twice 100% ethanol), each for 30 minutes. To achieve high throughput, the embryonic heart was collected and placed in a 96-well plate, and an automatic dehydrator (NAYO A1 / A8, Naiyou Biotechnology Co., Ltd.) was used to achieve rinsing and dehydration.
[0059] (3) A commercially available hollow ear spoon (width: about 3.8 mm, length: about 158 mm) was used to transfer the embryonic heart without introducing excessive alcohol into a benzyl alcohol:benzyl benzoate (volume ratio: 1:2, referred to as BABB) solution for dehydration and clearing (the BABB solution also has a certain degreasing effect). The dehydrated heart was transferred to a glass tube containing 100 μl of BABB solution and cleared at room temperature for 30 minutes.
[0060] (4) Using the ZEISS Lightsheet Z1 light sheet microscope platform, using homemade equipment ( Figures 1 to 3 The samples were fixed and replaced using an X5 / 0.16 air detection lens (n=1.45) and an X5 / 0.1 illumination lens. The transparentized heart was immersed in a BABB solution in a glass tube, and the glass tube was immersed in an imaging chamber filled with an 87% volume concentration of glycerol aqueous solution (refractive index RI of approximately 1.45) for imaging. Tissue autofluorescence imaging was performed using a 561 nm laser line scan.
[0061] (5) After imaging, Imaris 10.0 software was used for three-dimensional reconstruction and analysis of the images.
[0062] 2. For imaging of embryonic hearts without fluorescence, the embryonic hearts were from mouse E18.5 embryos. The fixation steps were different from those in (a) above, and the remaining steps were the same. The specific fixation steps were as follows: In order to enhance the autofluorescence of the tissue, the sample was directly fixed with 2.5% glutaraldehyde for 2 hours at room temperature.
[0063] The results are as follows Figure 5 The following are representative images of embryonic hearts at different stages taken with the ZEISS Lightsheet Z.1 using the above method. A1-F1 are three-dimensional representative images, A2-F2 are representative slices of the heart ventral side, showing the remodeling process of the outflow tract endothelial cushions, and A3-F3 are representative slices of the heart dorsal side, showing the remodeling process of the atrioventricular endothelial cushions. A4-F5 are three-dimensional cross-sectional images of the heart, and A4-E4 and A5-E5 are renderings of the heart endothelial cushions. The red arrows in A2 and A3 indicate the clearly visible endothelial cells on the inner side of the heart during the development of trabeculae at E10.5 days. A4 shows that the endothelial cushions of the septal outflow tract are in direct contact with the ventricular septum developed from trabeculae at E10.5 days. In B2 and B4, the aortic orifice and pulmonary artery orifice have not yet been clearly separated at the distal end of the outflow tract at E11.5 days. The superior atrioventricular endothelial cushions (savc) and the inferior atrioventricular endothelial cushions (iavc) can be seen in B3 and B5. In C2 and C4, at E12.5, the aortic orifice and pulmonary orifice can be clearly separated at the distal end of the outflow tract. In C5, the left and right atrioventricular endocardial cushions gradually develop, but the volume is small. In D2 and D4, at E13.5 days, the atrioventricular endocardial cushions fuse with each other, and there is no obvious morphological boundary. The arterial valve structure developed from the outflow tract can be seen. In D3 and D5, the superior atrioventricular endocardial cushions and the inferior atrioventricular endocardial cushions fuse with each other, and the red arrows show that there is still communication between the left and right chambers. E2-E5: A four-chamber heart with complete separation is formed at E14.5 days. F2-F5 shows the complete valve structure after the atrioventricular endocardial cushions are remodeled at E18.5 days. Right ventricle (RV), left ventricle (LV), outflow tract (OFT), right atrium (RA), left atrium (LA), aorta (AO), pulmonary artery (PA), parietal outflow tract endothelial cushion (PC), septal outflow tract endothelial cushion (SC), superior atrioventricular endothelial cushion (SAVC), inferior atrioventricular endothelial cushion (IAVC), right atrioventricular endothelial cushion (RLAVC), left atrioventricular endothelial cushion (LLAVC), aortic valve (AV), mitral valve (MV), tricuspid valve (TV).
[0064] The ZEISS Lightsheet Z1 light sheet microscope platform can obtain about 30 images of the transparent three-dimensional structure of the mouse embryonic heart per hour. For the embryonic heart of E10.5-E12.5, the X and Y axis resolution is less than 1μm, and the Z axis resolution is 1-2μm. For the embryonic heart of E18.5, the X and Y axis resolution is about 2μm, and the Z axis resolution is 5-7μm. This has realized a high-throughput imaging method for obtaining clear three-dimensional structures of the mouse embryonic heart.
[0065] Example 2
[0066] For imaging of embryonic hearts with fluorescence, embryonic hearts were derived from mice at E11.5 Wnt1-Cre; Rosa26mTmG Mouse embryos and Mef2C-Cre; Rosa26 at E11.5, E15.5, and E18.5 mTmG Mouse embryos. Mef2C-Cre mice were donated by Professor Zhang Zhen from Shanghai Jiao Tong University; Wnt1-Cre mice and Rosa26 mTmG Mice were purchased from Jackson Laboratory, USA, Wnt1-Cre; Rosa26 mTmG Mice were derived from Wnt1-Cre mice and Rosa26 mTmG Mice were mated to obtain Mef2C-Cre; Rosa26 mTmG Mice were derived from Mef2C-Cre mice and Rosa26 mTmG Mice are mated.
[0067] The specific steps are as follows:
[0068] (1) Fix in 4% formaldehyde at 4°C overnight.
[0069] (2) The collected hearts were incubated in glass bottles containing tetrahydrofuran (THF, purchased from Millipore-Sigma, catalog number 186562, prepared with water at different volume concentrations) at 10%, 20%, and 30% volume concentrations for lipid removal. For embryos older than E12.5 days, an additional 40% THF step was added to ensure thorough delipidation, and each step lasted for 30 minutes on a shaker at room temperature.
[0070] (3) After a brief rinse with water, the sample was transferred to a specially designed glass tube containing 100 μL of EZ view solution (refractive index RI of about 1.51), and the sample was incubated at room temperature for one hour to achieve optimal transparency. In this embodiment, since BABB solution quenches fluorescence, BABB cannot be used to make fluorescent samples transparent.
[0071] The EZ view solution configuration reference (Hsu, C.-W., Cerda, J., Kirk, JM, Turner, WD, Rasmussen, TL, Flores Suarez, CP, Dickinson, ME, and Wythe, JD (2022). EZClear for simple, rapid, and robust mouse whole organ clearing. eLife 11, e77419.10.7554 / eLife.77419.), also known as iohexol-urea solution, is composed of 5g iohexol and 2.625g urea dissolved in 2ml 0.03M PBS buffer, and the final concentration of PBS is about 0.01M (Note: The PBS published in the EZ view reference uses 0.02M PBS, and we found that the volume will increase to 3 times the original after dissolution, so we use 0.03M PBS). The refractive index RI is about 1.51.
[0072] (4) The imaging method is the same as in Example 1, and suitable excitation light (488 nm and 561 nm) is selected for imaging.
[0073] like Figure 6 The results of different delipidation times and delipidation concentrations are shown. AF: E11.5Wnt1-Cre; Rosa26 mTmG Gross and section images of mouse embryonic heart. AB: 10% THF-20% THF-30% THF degreasing, half an hour each, after transparentization, the normal morphology of the heart structure is revealed. The distribution of green fluorescent cells is clearly visible. CD: 10% THF-20% THF-30% THF-40% THF-50% THF degreasing, half an hour each, the overall structure of the heart is obviously wrinkled. EF: 10% THF-20% THF-30% THF degreasing, 3 hours each, the left and right atria and left and right ventricles are obviously wrinkled. Right ventricle (rv), left ventricle (lv), outflow tract (oft), right atrium (ra), left atrium (la), wall outflow tract endothelial cushion (pc), septal outflow tract endothelial cushion (sc), superior atrioventricular endothelial cushion (savc), inferior atrioventricular endothelial cushion (iavc). Scale bar: 200μm. Figure 6 The CF in the figure is used as a comparison for degreasing conditions, indicating that too high a THF concentration or too long a degreasing time used for degreasing can lead to shrinkage of the heart structure.
[0074] like Figure 7 The image shown is of Mef2C-Cre; Rosa26 taken with ZEISS Lightsheet Z.1 using the above method. mTmGRepresentative images of mouse embryos. AC: Gross images and sagittal sections of E11.5 mice. It can be seen that green fluorescent cells derived from Mef2C are mainly distributed in the outflow tract myocardial wall, right ventricle and ventricular septum. The green fluorescent cells indicated by white arrows are partially distributed in the intimal cushions of the outflow tract and a small amount in the intimal cushions of the atrioventricular septum. DF: Gross images and sections of E15.5 mice. It can be seen that green fluorescent cells are almost invisible in the tricuspid valve and mitral valve (E, representative image of the coronal section), and are distributed on the three leaflets of the aortic valve and pulmonary valve (F, representative image of the transverse section). GI: Gross images and coronal sections of E18.5 mice. It can be seen that green fluorescent cells are distributed in large numbers in the pulmonary valve and aortic valve, right ventricle and ventricular septum, and are almost invisible in the mitral valve. Right ventricle (RV), left ventricle (LV), outflow tract (OFT), right atrium (RA), left atrium (LA), parietal outflow tract endocardial cushions (PC), septal outflow tract endocardial cushions (SC), superior atrioventricular endocardial cushions (SAVC), inferior atrioventricular endocardial cushions (IAVC), pulmonary valve (PV), aortic valve (AV), mitral valve (MV), tricuspid valve (TV), ventricular septum (S), left coronary valve (LC), right coronary valve (RC), non-coronary valve (NC), left-facing leaflets (LF), right-facing leaflets (RF), non-opposing leaflets (NF).
Claims
1. A high-throughput imaging method for acquiring the three-dimensional structure of the embryonic heart of an experimental animal, characterized in that: The following steps are involved: (1) Collect the embryonic hearts of experimental animals and fix them using fixative; (2) Dehydrating or defatting the embryonic heart fixed in step (1) and then performing a transparent treatment; (3) The embryonic heart after the clearing treatment was placed in a transparent tube, and then placed in an imaging chamber filled with a transparent solution with a refractive index of 1.41 to 1.47, and fluorescence imaging was performed.
2. The high-throughput imaging method for acquiring the three-dimensional structure of the embryonic heart of an experimental animal according to claim 1, characterized in that: If the embryonic heart does not express exogenous fluorescent proteins, imaging was performed using the enhanced tissue autofluorescence method; If the embryonic heart expresses exogenous fluorescent protein, the excitation light corresponding to the exogenous fluorescent protein is used for fluorescence imaging.
3. The high-throughput imaging method for acquiring the three-dimensional structure of the embryonic heart of an experimental animal according to claim 2, characterized in that: If the embryonic heart does not express exogenous fluorescent proteins, imaging can be performed using enhanced tissue autofluorescence, in which case: In step (1), the embryonic heart of the experimental animal is from an embryo of E10.5 to E14.5, and when fixation is performed using a fixative, formaldehyde solution is first used for fixation and then glutaraldehyde solution is used for fixation; In step (1), the embryonic heart of the experimental animal is from an embryo of E15.5 to E18.5, and is fixed with a glutaraldehyde solution; If the embryonic heart expresses exogenous fluorescent protein, the excitation light corresponding to the exogenous fluorescent protein is used for fluorescence imaging. In this case, in step (1), formaldehyde solution is used for fixation.
4. The high-throughput imaging method for acquiring the three-dimensional structure of the embryonic heart of an experimental animal according to claim 3, characterized in that: When using formaldehyde solution for fixation, the fixation time shall not be less than 2 hours; when using glutaraldehyde solution for fixation, the fixation time shall not be less than 2 hours.
5. The high-throughput imaging method for acquiring the three-dimensional structure of the embryonic heart of an experimental animal according to claim 2, characterized in that: If the embryonic heart does not express exogenous fluorescent proteins, imaging can be performed using enhanced tissue autofluorescence, in which case: In step (2), the sample is first washed with a buffer solution, then dehydrated, and then degreased and transparentized; the dehydration is performed using an alcohol solution with increasing concentrations until pure alcohol, and then degreased and transparentized using a benzyl alcohol: benzyl benzoate solution; If the embryonic heart expresses exogenous fluorescent protein, the excitation light corresponding to the exogenous fluorescent protein is used for fluorescence imaging. At this time: In step (2), degreasing is performed using tetrahydrofuran solutions with increasing concentrations in a gradient manner; and iohexol-urea solution is used for transparent treatment.
6. The high-throughput imaging method for acquiring the three-dimensional structure of the embryonic heart of an experimental animal according to claim 5, characterized in that: When the dehydration is performed using an alcohol solution with a concentration increasing in sequence until pure alcohol, the volume concentration gradient of the alcohol is set to 50%, 75%, 90%, 100% and 100% in sequence; the processing time for each volume concentration gradient is 30 minutes; The volume ratio of benzyl alcohol to benzyl benzoate in the benzyl alcohol: benzyl benzoate solution is 1:2; When degreasing using tetrahydrofuran solutions with increasing concentrations for gradient degreasing, for embryonic hearts less than E12.5 days, the volume concentration gradient of the tetrahydrofuran solution is set to 10%, 20%, and 30% in sequence; for embryonic hearts more than E12.5 days, the volume concentration gradient is increased to 40%; the treatment time for each volume concentration gradient is 30 minutes; The composition of the iohexol-urea solution is 5 g of iohexol and 2.625 g of urea dissolved in 2 ml of 0.03 M PBS buffer.
7. The high-throughput imaging method for acquiring the three-dimensional structure of the embryonic heart of an experimental animal according to claim 1, characterized in that: During the clearing treatment, the sample is placed in a transparent tube and fluorescence imaging is performed directly after the clearing treatment.
8. The high-throughput imaging method for acquiring the three-dimensional structure of the embryonic heart of an experimental animal according to claim 1, characterized in that: For fluorescence imaging, the ZEISS Lightsheet Z1 light sheet microscope platform was used for fluorescence imaging, using an X5 / 0.16 air detection lens and an X5 / 0.1 illumination lens; The imaging chamber was perfused with a glycerol aqueous solution having a volume concentration of 87%.
9. The high-throughput imaging method for acquiring the three-dimensional structure of the embryonic heart of an experimental animal according to claim 8, characterized in that: During fluorescence imaging, a first magnet is fixed to the bottom end of the sample fixing rod of the ZEISS Lightsheet Z1 light sheet microscope platform, and a sampling rod is used to fix the transparent tube on the sample fixing rod. The sampling rod has a certain elasticity, and a second magnet for being attracted and fixed to the first magnet by opposite charges is provided on the top surface, and a plug-in section for plugging into the inner cavity of the transparent tube and with a diameter gradually decreasing from top to bottom is provided on the bottom.
10. The high-throughput imaging method for acquiring the three-dimensional structure of the embryonic heart of an experimental animal according to claim 1, characterized in that: The experimental animals are mice or rats.
Citation Information
Patent Citations
Rapid tissue transparent processing method based on water-soluble reagent and application thereof
CN109632420A
Methods for large tissue labeling, clearing and imaging
CN110998277A
Animal tissue transparentizing method
CN111735681A
Method for rapidly and quantitatively detecting methylmalonic acid in biological sample based on liquid chromatography-mass spectrometry
CN117929564A
KR20200126879A
Cited By
Embryo-like sample loading device of light sheet microscope and living body imaging method
CN120928556A
